Edi Brogi Selected Research

4- (2- hydroxy- 3- tert- butylaminopropoxy)- 2- methylindole (21-009)

7/2012

Differentially expressed genes in window trials are influenced by the wound-healing process: lessons learned from a pilot study with anastrozole.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edi Brogi Research Topics

Disease

64	Breast Neoplasms (Breast Cancer) 03/2022 - 10/2003
63	Neoplasms (Cancer) 01/2022 - 04/2003
16	Carcinoma (Carcinomatosis) 01/2021 - 11/2003
11	Neoplasm Metastasis (Metastasis) 01/2019 - 12/2007
9	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 11/2005
6	Triple Negative Breast Neoplasms 01/2021 - 10/2012
4	Mucinous Adenocarcinoma (Mucinous Carcinoma) 07/2019 - 05/2013
3	Fibroadenoma 02/2022 - 08/2006
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2006
3	Disease Progression 07/2021 - 01/2019
3	Pathologic Complete Response 01/2021 - 08/2019
3	Papillary Carcinoma 01/2020 - 08/2017
3	Lymphatic Metastasis 01/2014 - 08/2006
2	Breast Carcinoma In Situ 05/2022 - 04/2015
2	Brain Neoplasms (Brain Tumor) 03/2022 - 12/2011
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2022 - 11/2011
2	Intraductal Papilloma 01/2020 - 01/2016
2	Necrosis 07/2019 - 09/2010
2	Adenomyoepithelioma 01/2018 - 08/2006
2	Ductal Carcinoma 01/2017 - 11/2005
2	Lobular Carcinoma 04/2015 - 11/2005
1	Rhabdoid Tumor (Rhabdoid Tumors) 10/2021
1	Small Cell Carcinoma 10/2021
1	Fibrocystic Breast Disease (Chronic Cystic Mastitis) 01/2021
1	Hemorrhage 07/2019
1	Gliosis 07/2019
1	Neoplasm Micrometastasis 01/2019
1	Papillary Thyroid Cancer 08/2018
1	Thyroid Neoplasms (Thyroid Cancer) 08/2018
1	Monosomy 01/2018
1	Adenocarcinoma 08/2017
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2017

Drug/Important Bio-Agent (IBA)

22	Estrogen ReceptorsIBA 01/2022 - 08/2006
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2006
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2005
9	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 12/2007
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2012
8	Hormones (Hormone)IBA 01/2022 - 05/2006
7	Cadherins (E-Cadherin)IBA 05/2022 - 11/2005
6	human ERBB2 proteinIBA 03/2021 - 12/2007
4	Monoclonal AntibodiesIBA 01/2022 - 11/2006
4	Estrogens (Estrogen)FDA Link 01/2018 - 05/2006
3	Trastuzumab (Herceptin)FDA Link 03/2022 - 08/2009
3	Formaldehyde (Formol)FDA Link 01/2022 - 07/2012
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2018
3	ParaffinIBA 01/2022 - 07/2012
3	AntigensIBA 01/2022 - 09/2010
3	atezolizumabIBA 01/2021 - 01/2020
3	MucinsIBA 07/2019 - 05/2013
3	LigandsIBA 01/2019 - 08/2012
2	Mediator ComplexIBA 02/2022 - 11/2015
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 08/2012
2	B7-H1 AntigenIBA 01/2022 - 01/2021
2	ChromatinIBA 10/2021 - 12/2020
2	Long Noncoding RNAIBA 12/2020 - 01/2016
2	AntibodiesIBA 01/2020 - 09/2013
2	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2018 - 02/2014
2	Tamoxifen FDA LinkGeneric 01/2017 - 04/2002
2	IpilimumabIBA 12/2016 - 10/2016
2	Eosine Yellowish-(YS) (Eosin)IBA 10/2016 - 04/2008
2	Hematoxylin (Haematoxylon)IBA 10/2016 - 04/2008
2	Phenobarbital (Luminal)FDA Link 08/2016 - 01/2016
2	Indicators and Reagents (Reagents)IBA 04/2015 - 10/2013
2	ErbB Receptors (EGF Receptor)IBA 09/2013 - 12/2008
2	Complementary DNA (cDNA)IBA 08/2012 - 07/2012
2	Messenger RNA (mRNA)IBA 12/2011 - 08/2006
2	Peptide Hydrolases (Proteases)FDA Link 12/2011 - 01/2006
2	Aromatase (CYP19)IBA 07/2011 - 05/2006
1	pertuzumabIBA 03/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2022
1	GlycosphingolipidsIBA 01/2022
1	3F8 antibodyIBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 10/2021
1	RNA (Ribonucleic Acid)IBA 12/2020
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2020
1	AlpelisibIBA 01/2020
1	Aromatase InhibitorsIBA 01/2020
1	Circulating Tumor DNAIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2019
1	Coloring Agents (Dyes)IBA 07/2019
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2019
1	AntioxidantsIBA 01/2019
1	Cyclin-Dependent Kinase 4IBA 12/2018
1	Mitogen-Activated Protein KinasesIBA 10/2018
1	bis(pyridinio)dichlorocuprate(II)IBA 08/2018
1	myocardinIBA 01/2018
1	Codon (Codons)IBA 01/2018
1	erucylphosphocholineIBA 08/2017

Therapy/Procedure

25	Therapeutics 01/2022 - 04/2008
8	Neoadjuvant Therapy 03/2022 - 01/2016
8	Drug Therapy (Chemotherapy) 06/2018 - 12/2011
7	Mastectomy (Mammectomy) 09/2017 - 04/2003
5	Immunotherapy 01/2022 - 10/2016
5	Segmental Mastectomy (Lumpectomy) 07/2021 - 08/2010
2	Cryosurgery 12/2016 - 10/2016
2	Radiotherapy 08/2016 - 04/2010
2	Prophylactic Mastectomy 09/2007 - 04/2003
1	Adjuvant Chemotherapy 01/2017